Tango Therapeutics, Inc. · NASDAQ:TNGX
Woodline Partners LP reported a 5.60% stake in Tango Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 14, 2025
Woodline Partners LP reported a 5.60% stake in Tango Therapeutics, Inc., 6,029,906 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 6,029,906
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Woodline Partners LP | 5.60% | 6,029,906 |
Source
Related
- Tango Therapeutics, Inc.
- Woodline Partners LP
- Tango Therapeutics, Inc. shareholders
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · May 15, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026